A multi-center survey of HPV knowledge and attitudes toward HPV vaccination among women, government officials, and medical personnel in China

Asian Pac J Cancer Prev. 2012;13(5):2369-78. doi: 10.7314/apjcp.2012.13.5.2369.

Abstract

Objectives: To assess knowledge of HPV and attitudes towards HPV vaccination among the general female population, government officials, and healthcare providers in China to assist the development of an effective national HPV vaccination program.

Methods: A cross-sectional epidemiologic survey was conducted across 21 urban and rural sites in China using a short questionnaire. 763 government officials, 760 healthcare providers, and 11,681 women aged 15-59 years were included in the final analysis. Data were analyzed using standard descriptive statistics and logistic regression.

Results: Knowledge of HPV among the general female population was low; only 24% had heard of HPV. Less than 20% of healthcare providers recognized sexually naive women as the most appropriate population for HPV vaccination. There was high acceptance of the HPV vaccine for all categories of respondents. Only 6% of women were willing to pay more than US $300 for the vaccine.

Conclusions: Aggressive education is necessary to increase knowledge of HPV and its vaccine. Further proof of vaccine safety and efficacy and government subsidies combined with increased awareness could facilitate development and implementation of HPV vaccination in China.

Publication types

  • Multicenter Study
  • Research Support, American Recovery and Reinvestment Act
  • Research Support, N.I.H., Extramural

MeSH terms

  • Administrative Personnel / statistics & numerical data*
  • Adolescent
  • Adult
  • Attitude to Health
  • China / epidemiology
  • Cross-Sectional Studies
  • Female
  • Health Knowledge, Attitudes, Practice*
  • Health Personnel / statistics & numerical data*
  • Humans
  • Male
  • Middle Aged
  • Papillomaviridae / pathogenicity
  • Papillomavirus Infections / epidemiology
  • Papillomavirus Infections / prevention & control*
  • Papillomavirus Infections / virology
  • Papillomavirus Vaccines / therapeutic use*
  • Prognosis
  • Surveys and Questionnaires
  • Uterine Cervical Neoplasms / epidemiology
  • Uterine Cervical Neoplasms / prevention & control*
  • Uterine Cervical Neoplasms / virology
  • Vaccination
  • Women's Health
  • Young Adult

Substances

  • Papillomavirus Vaccines